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Abstract 
The aim of this thesis was to investigate the chemical and biochemical properties of the 
Malian medicinal plants Terminalia macroptera and Biophytum umbraculum, with main 
focus on its phenolic substances. This thesis is a part of a research project in which the 
ultimate goal is to provide efficient, non-toxic and inexpensive medicines for the Malian 
population. 
Extraction and purification of fractions from T. macroptera resulted in the isolation of 
several polyphenolic compounds such as hydrolyzable tannins and flavonoids. Chebulic acid 
trimethyl ester is a novel compound isolated from T. macroptera. B. umbraculum was found 
to be a good source of flavone-C-glycosides, and cassiaoccidentalin A, a rare natural 
product, was the major one. The crude extracts and pure compounds obtained were tested in 
various in vitro bioassays to determine their bioactivity as antioxidants, Į-glucosidase 
inhibitors, antimalarial agents as well as their toxicity.  
Ethnopharmacological studies revealed that 86 % of the traditional practitioners used T. 
macroptera for a variety of medical indications such as wounds, pain, cough, tuberculosis, 
hepatitis, and diabetes. The semipolar extracts, the ethyl acetate (EtOAc) extract in 
particular, were found to be very strong Į-glucosidase inhibitors, strong 1,1-diphenyl-2-
picrylhydrazyl (DPPH)  radical scavengers and 15-lipoxygenase (LO) inhibitors, and 
moderate xanthine oxidase (XO) inhibitors. None of the extracts or the isolated compounds 
seemed to be very toxic towards brine shrimp larvae. 
B. umbraculum was used for treating cerebral malaria (CM) by more than 50 % of the 
interviewed traditional practitioners, and was thus tested in two CM-related in vitro assays in 
addition to the antiplasmodial activity assay. The semipolar plant extracts showed high 
complement inhibition of the classical pathway and dose-dependent inhibition of nitric oxide 
(NO) release from activated macrophages. Additionally, the EtOAc extract displayed 
moderate antimalarial activity against the erythrocyte stages of Plasmodium falciparum. The 
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antioxidant activity was also evaluated, and the semipolar extracts displayed strong radical 
scavenging and 15-LO inhibitory effects, but less activity towards XO.
 1
1. Introduction
1.1 Mali 
Mali is a landlocked country located in West Africa (Figure 1.1). With an area of 
approximately 1,240,000 km2, it is actually one of the biggest countries in Africa, based on 
size. Despite the large area, the majority of the population lives in rural areas along the river 
Niger in the south since 2/3 of the land area is desert or semi-desert. The country is 
composed of various climatic zones and populated by a diversity of ethnic groups (Diallo & 
Paulsen, 2000; OperationWorld, 2013). 
According to the  Human Development Report of 2013, Mali is ranked as number 182 of 
187 countries and categorized as a “low human development” country, whilst Norway in 
contrast is ranked as number one and “very high human development” (Malik, 2013).  Being 
one of the poorest countries in the world, Mali faces numerous health challenges related to 
the high prevalence of infectious diseases and parasites in combination with low availability 
of medicines and a poor healthcare system. To meet their health care needs, the Malian 
people use both conventional and traditional medicine. And because of the price increase of 
conventional medicine in the local currency, the use of traditional medicine has further 
increased (Diallo et al., 2002).  
Figure 1.1: Map of Mali (OperationWorld, 2013) 
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1.2 Traditional medicine 
Traditional medicine is the total sum of knowledge, skills and practices based on the 
theories, beliefs and experiences indigenous to different cultures that are used to maintain 
health, as well as to prevent, diagnose, improve or treat physical and mental illnesses (WHO, 
2008). Traditional medicine is also known as alternative, non-conventional or 
complementary medicine, although none of these designations are fully equivalent to 
traditional medicine. However, traditional medicine is not an alternative to 
modern/conventional medicine, but in fact complementary in most developing countries 
(Iwu, 2002). In Mali, approximately 75 % of the population relies on traditional medicines 
for their primary health care (Robinson & Zhang, 2011). The traditional medicine is mainly 
based on plants, and many of these plants have never been investigated for their chemical 
and biological properties. It is therefore essential to evaluate scientifically the benefits, risks 
and limitations of Malian medicinal plants to provide a better health care system for the 
Malian people. 
Since 1996, the Pharmacognosy section at the Department of Pharmaceutical Chemistry, 
School of Pharmacy, University of Oslo has collaborated with the Department of Traditional 
Medicine (DMT), Bamako, Mali. DMT is a collaborating center of the World Health 
Organization (WHO) for research in traditional medicine. One of the primary objectives of 
the collaboration is to assure that traditional medicine is complementary to conventional 
medicine, assuming that the medicines can be produced from local resources, especially 
from medicinal plants. The main activity of DMT is to collaborate with the traditional 
practitioners and to register their use of medicinal plants, in addition to research and 
development of improved traditional medicines (ITMs) from local plants. So far DMT have 
developed twelve ITMs, and seven of these are acknowledged as essential medicines in 
Mali. These ITMs have undergone extensive phytochemical, pharmacological and 
toxicological investigation and are standardized according to traditional administration 
regimes (Diallo & Paulsen, 2000).  
The collaboration between the Section of Pharmacognosy and DMT has mainly focused on 
identifying bioactive polysaccharides from Malian medicinal plants used in the treatment of 
wounds (Austarheim et al., 2012; Diallo et al., 2002; Inngjerdingen et al., 2004). The 
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medicinal plants investigated in this collaborating project are chosen by the DMT as 
potential candidates for new ITMs. As plant polysaccharides are polar, it is usually the water 
extracts of the chosen plants that have been investigated, and little is known about the low 
molecular weight compounds of the lipophilic and semipolar extracts of these medicinal 
plants. It is therefore highly interesting to study the low molecular weight compounds in 
these extracts as possible active substances in the Malian medicinal plants. 
1.3 Investigated plants 
As mentioned earlier, the plants investigated are chosen by the DMT as potential candidates 
for new ITMs. In addition, limited chemical data has been reported on these species 
previously. 
1.3.1  Terminalia macroptera Guill. & Perr. (Combretaceae) 
Terminalia macroptera Guill. & Perr. (Combretaceae; syn. Myrobalanus macroptera
Kuntze) is a tree, up to 20 meters high (Figure 1.2), which grows from Senegal to Cameroon, 
and as far east as Sudan. It is common and scattered, and thrives in savannahs and poorly-
drained clay soils. According to Arbonnier (2004), the leaves have been used traditionally to 
treat gastritis, colic, fever, skin diseases, tuberculosis and high blood pressure. The roots are 
astringent and are used against cough, jaundice, syphilis, urinary infections among other 
diseases. Recent ethnobotanical and ethnopharmacological surveys have reported use against 
cough, snakebite (Sourabie et al., 2013), malaria, liver disorders, urinary retention, diarrhea, 
skin diseases, epilepsy, convulsion, gastric ulcer (Etuk et al., 2009; Ige, 2011; Nadembega et 
al., 2011; Oluranti et al., 2012; Traore et al., 2013), piles, constipation (Kayode et al., 2009a; 
Odugbemi, 2008; Wodah & Asase, 2012) and sexually transmitted diseases (STD) (Kayode 
et al., 2009b). In vitro studies have revealed antioxidant (Kone et al., 2012), antimicrobial 
(Silva et al., 1996; Silva et al., 1997), antifungal (Batawila et al., 2005), anti-inflammatory 
(Bernard et al., 2001), antiepileptic, anticonvulsant (Pedersen et al., 2009), antiplasmodial 
(Sanon et al., 2003), anti-Neisseria gonorrhoeae (Silva et al., 2002), anti-Helicobacter pylori
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(Silva et al., 2012) as well as haemolytic (Karou et al., 2012) effects of T. macroptera. 
Chemical studies have shown that this tree is rich in hydrolyzable tannins, triterpenes,  
(Conrad et al., 2001a; Conrad et al., 1998; Conrad et al., 2001b; Kraus et al., 2002; Silva et 
al., 2000) benzoic and cinnamic acids (Kone et al., 2012), and flavonoids (Batawila et al., 
2005). However, most of these studies are carried out on of the roots and bark of T. 
macroptera, and very few studies had been performed on the leaves until we started 
phytochemical studies on the leaves of this plant. It is very important if the leaves can be 
used rather than the roots and bark as this will help to ensure a more sustainable conservation 
of biodiversity. This is especially since T. macroptera is one of the more frequently used 
trees as a resource of fuelwood and timber, and is therefore in threat of extinction (Asase & 
Oteng-Yeboah, 2012; Lykke, 1998; Tee et al., 2009; Zida et al., 2008). 
Figure 1.2: Terminalia macroptera Guill. & Perr. (Combretaceae). The local name is woloba (Photo: 
A.T. Pham).
1.3.2  Biophytum umbraculum Welw. (Oxalidaceae)
According to The Plant List (2013), Biophytum petersianum Klotzsch. is a synonym of the 
accepted name Biophytum umbraculum Welw. (Oxalidaceae). However, almost all scientific 
papers published have used the name B. petersianum, but the accepted name will be used 
throughout this thesis. B. umbraculum (B. petersianum) has also in many cases been used 
synonymous with Biophytum sensitivum (L.) DC., but these species are considered as two 
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distinct species (Farooqui et al., 1985; Lourteig, 1981). B. umbraculum is a slender annual 
herb with stems up to 25 cm long and leaves, which are very sensitive, in a terminal crown 
(Figure 1.3). The plant is widespread in tropical and subtropical regions of Africa, and across 
Asia to New Guinea (Burkill, 1997). B. umbraculum has been used traditionally in Nigeria 
for the treatment of wounds, gonorrhea, urinary stones and stomachache. In Gabon and Zaïre 
it is used as a purgative, in Togo for hypertension, and in New Guinea the plant is believed 
to increase fertility (Burkill, 1997; Mouzou et al., 2010). In an ethnopharmacological survey 
conducted in Mali in 2011 we found that B. umbraculum is used against cerebral malaria 
(Paper V). Two earlier ethnopharmacological surveys from Mali also reported the use 
against malaria (Grønhaug et al., 2008; Inngjerdingen et al., 2006). Additionally, the 
indications fever, wounds, and different types of pain were reported (Diallo et al., 2002; 
Grønhaug et al., 2008; Inngjerdingen et al., 2006).
  
Figure 1.3: Aerial parts of Biophytum umbraculum Welw. (Oxalidaceae). (Photo: D. Diallo)
In vitro studies demonstrated that B. umbraculum stimulated corticosterone and aldosterone 
secretion in rats (Kodjo et al., 2006) and exerted calcium antagonistic activity on vascular 
smooth cells in Wistar rats (Titrikou et al., 2007). Antagonistic effect on calcium release 
from sarcoplasmic reticulum in skeletal muscle cells has also been shown (Mouzou et al., 
2010), and the mechanism underlying the hypotensive effect was not a result of sympathetic 
nervous system inhibition, but partially involved stimulation of the parasympathetic system 
(Titrikou et al., 2008) and peripheral vasodilatation (Titrikou et al., 1998). These results may 
explain the use of B. umbraculum as an antihypertensive in traditional medicine. Pectic 
polysaccharides from B. umbraculum have shown immunomodulatory activities in 
    6
biological screening assays, with effects varying from complement fixation (Diallo et al., 
2002; Inngjerdingen et al., 2006) to potent activation of macrophages and of dendritic cells 
(Inngjerdingen et al., 2008), as well as impact on intestinal Peyer’s patch cells (Grønhaug et 
al., 2011). A recent study showed that pectic polysaccharides isolated from aerial parts of B. 
umbraculum were able to protect against Streptococcus pneumonia infection in mice 
(Inngjerdingen et al., 2013). 
1.4 General aspects of isolated polyphenols 
Polyphenols are a large group of phytochemicals, with structural features characterized by 
the presence of one or more phenolic units (benzene ring with OH groups). Since this is a 
fairly common feature, this group is very diverse and contains several sub-groups, the major 
ones being flavonoids, phenolic acids, hydrolyzable tannins, stilbenes and lignans. Plant-
based foods and beverages such as fruits, berries, vegetables, chocolate, tea and wine are rich 
sources of polyphenols. Most of the natural phenols are derived from secondary plant 
metabolism of the shikimic acid pathway, acetate-polymalonate pathway or both (Knaggs, 
2001; Landete, 2012; Tsao, 2010). Shikimic acid is the key intermediate in the shikimic acid 
pathway and subsequently essential in the biosynthesis of many plant phenolics such as 
flavonoids (Herrmann & Weaver, 1999; Taiz & Zeiger, 2010). Shikimic acid is also a central 
precursor in the gallic acid biosynthesis, which in turn is a key intermediate for the synthesis 
of plant hydrolyzable tannins (Grundhofer et al., 2001; Muir et al., 2011; Werner et al., 
2004).  
1.4.1  Flavonoids 
Flavonoids are a large group of naturally occurring polyphenolic compounds that are 
secondary metabolites, extensively spread throughout the plant kingdom. The structure of 
flavonoids consists of a C15 unit with two benzene rings A and B connected by a three-
carbon chain. This chain is closed in most flavonoids, forming the heterocyclic ring C 
(Figure 1.4). The basic structure of a flavonoid allows a wide variety of different substitution 
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in the A, B and C rings, resulting in multiple subclasses. Classification of flavonoids into 
subclasses is based on the functional groups in the C-ring; e.g. flavones, flavonols, 
flavanones, flavan-3-ols, isoflavones and anthocyanidins (Habauzit & Morand, 2012). 
Flavonoids in nature are most often found as glycosides, methyl ethers and other conjugates. 
The sugar moiety helps to facilitate water solubility and transportability of the aglycone 
(Davies & Yáñes, 2013). Glycosides can either be O- or C- linked. The variation of 
flavonoid glycosides are based on the number of positions on the flavonoid for 
glycosylation, the level of glycosylation and the number of types of sugars involved in 
glycosylation (Ghasemzadeh & Ghasemzadeh, 2011).  
Flavonoids are important constituents of the human diet and are found in herbs, vegetables, 
fruits, cocoa, soybeans, berries, wine, and tea. Many plants are rich in flavonoids. Flavonoids 
are important not only for the plants, but also for humans and other animals. These 
compounds are acknowledged for having interesting medicinal properties, such as 
vasodilatory, anti-inflammatory, antiallergic, hepatoprotective, antithrombotic, 
anticarcinogenic, antiviral, antibacterial, antitumor, and enzyme inhibitory activities. They 
are also well known for their antioxidant and radical scavenging activities (Corradini et al., 
2011; Cotelle et al., 1996; Rice-Evans et al., 1995).   
Figure 1.4: Structure of the flavonoid skeleton and some flavonoid subclasses (Del Rio et al., 2013).
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1.4.1.1 Flavonols 
Flavonols are a subclass of flavonoid compounds with a C2-C3 double bond and a hydroxyl 
group (OH) attached at the 3-position (3-hydroxyflavones) in the C-ring. These compounds 
are very widespread in higher plants where they usually occur in the leaves and outer parts of 
the plant. This is due to the dependence of light for their formation (Herrmann, 1976). About 
450 different flavonol aglycones have been identified in plants (Corradini et al., 2011). In 
human diet, apples, plums, cranberries, strawberries, grapes, onions, broccoli and tomatoes 
are major food sources of flavonols. Beverages like red wine, tea and grape juice also 
contain large amounts (Habauzit & Morand, 2012). The majority of flavonols are present as 
O-glycosides, where one or more of the aglycone OH groups are bound to a sugar with 
formation of an O-C acid-labile acetal bond. The preferred position for glycosylation is 3-
hydroxyl, and less frequently the 7-hydroxyl (Corradini et al., 2011; Herrmann, 1976). 
Flavonols have been identified as some of the best phenolics with antioxidant activity in 
wine, especially in white wines, although their antioxidant effects in red wines are usually 
exceeded by other more abundant phenolics, like flavan-3-ols and anthocyanins (Castillo-
Munoz et al., 2009). 
1.4.1.2 Flavones 
Flavones are similar structurally to flavonols, except they lack oxygenation at C-3 (Figure 
1.4). The flavones are not distributed as widely as flavonols, although substantial amounts 
have been detected in celery, parsley, sweet pepper, some herbs (Del Rio et al., 2013; 
Habauzit & Morand, 2012), as well as some medicinal plants (Du et al., 2010; Haraguchi et 
al., 2003; Wang et al., 2012). A wide range of substitutions is possible with flavones, 
including hydroxylation, methylation, O- and C-glycosylation, and alkylation (Del Rio et al., 
2013; Habauzit & Morand, 2012). Flavones occur mainly as 7-O-glycosides (Hollman & 
Arts, 2000), but less frequently, glycosylation may take place by direct linkage of the sugar 
to the flavone basic nucleus, via an acid-resistant C-C bond, to form flavone-C-glycosides. 
Glucose is the most commonly encountered monosaccharide, whereas disaccharides and 
even higher saccharides are also found in association with flavones, the more common being 
the disaccharide rutinose (Corradini et al., 2011).  
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1.4.2  Hydrolyzable tannins 
Plant tannins form one of the major groups of antioxidant polyphenols found in food and 
beverages. They have attracted considerable attention in recent years because of their 
multifunctional properties beneficial to human health (Yoshida et al., 2010). Tannins can be 
divided into four major groups based on their structural characteristics; gallotannins, 
ellagitannins, complex tannins and condensed tannins (proanthocyanidins) (Khanbabaee & 
van Ree, 2001) (Figure 1.5). Phlorotannins, condensed phloroglucinol derivatives, form a 
further group of tannins with limited distribution, being found in seaweeds (Singh & 
Bharate, 2006). Hydrolyzable tannins are polyesters of a sugar moiety and organic acids. The 
designation “hydrolyzable tannin” is due to the fact that these compounds undergo 
hydrolytic cleavage to the respective sugar and acid moiety upon treatment with diluted 
acids or they may be hydrolyzed by enzymes. If the acid component is gallic acid, the 
compounds are called gallotannins. Esters with hexahydroxydiphenic (HHDP) acid or ellagic 
acid are called ellagitannins (Serrano et al., 2009). 
Figure 1.5: Classification of tannins. The hydrolyzable tannins consist of gallotannins, ellagitannins 
and complex tannins (Khanbabaee & van Ree, 2001). 
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1.4.2.1 Ellagitannins 
Ellagitannins constitute a complex class of polyphenols characterized by one or more HHDP 
or ellagic acid moieties esterified to a sugar unit, usually glucose (Figure 1.6). HHDP 
moieties are constituted by oxidative biaryl coupling (C-C coupling) between suitably 
orientated neighbouring galloyl residues (Landete, 2011; Niemetz & Gross, 2005). 
Ellagitannins are widely distributed in the nature, with more than 500 natural products 
characterized so far, making ellagitannins the largest group of known tannins (Khanbabaee 
& van Ree, 2001). They have been reported in berries, fruits, nuts, peas and oak-aged wines 
(Serrano et al., 2009). Ellagitannins are hydrolyzed to ellagic acid under physiological 
conditions in vivo and ellagic acid is then gradually metabolized by the intestinal microbiota 
to produce different types of urolithins, that are considered as biomarkers for human 
exposure to dietary ellagitannins (Landete, 2011; Serrano et al., 2009). A wide range of 
significant biological activities beneficial to human health have been reported for 
ellagitannins. Antioxidant, astringent, antimicrobial, antitumor, antihypertensive, anti-
inflammatory, enzyme-inhibitory and immunomodulatory properties are some of the effects 
demonstrated (Chen et al., 2009; Landete, 2011; Okuda, 2005; Okuda & Ito, 2011; Serrano 
et al., 2009; Vrhovsek et al., 2006; Yoshida et al., 2010). However, the evidence for the 
benefit of ellagitannins comes primarily from animal or in vitro studies, and additional 
clinical trials are needed to better understand their role as therapeutic agent, especially since 
there are very limited data on their bioavailability and metabolism in the human body.  
Figure 1.6: Example of a structure of an ellagitannin, chebulagic acid (Lin et al., 2011). 
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1.5 Biological activitites  
1.5.1  Free radicals and antioxidant activity  
There is a considerable interest in antioxidants, as they may exert beneficial effects in human 
health. It has been suggested that polyphenols such as flavonoids and tannins play a role as 
antioxidants by inhibiting lipid peroxidation including low density lipoprotein (LDL) 
oxidation and scavenging free radicals. These polyphenols may act as antioxidants because 
of the hydrogen-donating capacity of their phenolic groups (Rice-Evans et al., 1995). 
Suggested mechanisms are: (1) scavenging reactive species (RS) such as reactive oxygen 
species (ROS)/reactive nitrogen species (RNS); (2) suppressing ROS/RNS formation by 
inhibiting radical-forming enzymes (in particular xanthine oxidase, NADPH oxidase and 
lipoxygenases) or chelating trace metals (iron and/or copper) involved in free radical 
production; (3) inhibition of  expression of inflammatory signalling molecules; (4)  up 
regulating or protecting antioxidant defence (Ghasemzadeh & Ghasemzadeh, 2011; 
Mladenka et al., 2010).   
Antioxidants are compounds that may protect human, animal and plant cells against the 
damaging effects of free radicals or other RS. Free radicals can be defined as any species 
containing one or more unpaired electrons in atomic or molecular orbitals and capable of 
independent existence (Halliwell, 2011). An imbalance between antioxidants and free 
radicals may result in oxidative stress and may lead to cellular damage. Because of this, 
oxidative stress has been suggested to be a major contributor to the pathogenesis of a number 
of human diseases as well as in the ageing process (Ghasemzadeh & Ghasemzadeh, 2011; 
Halliwell & Gutteridge, 2007; Valko et al., 2007). For this reason, antioxidant activity is one 
of the most commonly determined biological activities in extracts of plants (Clarke et al., 
2013).  
For a polyphenol to be defined as an antioxidant it must satisfy two basic conditions: first, 
when present in low concentration relative to the substrate to be oxidized it can delay, retard, 
or prevent the autoxidation or free radical-mediated oxidation; second, the resulting radical 
formed after scavenging must be stable (Rice-Evans et al., 1996). In order to determine 
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antioxidant activity, many tests use accelerated oxidative conditions which provoke 
oxidation. 
Major antioxidant capacity assays can roughly be classified into two categories: the 
hydrogen atom transfer (HAT) reaction based assays and the single electron transfer (ET) 
reaction based assays. The ET-based assays measure an antioxidants’ reducing capacity, 
while the HAT-based assays quantify hydrogen atom donating capacity (Huang et al., 2005).  
Scavenging of 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical is a rapid, simple and accurate 
method for estimating the efficiency of substances as antioxidants. The assay is based on the 
spectrophotometric measurement (515-520 nm) of the DPPH concentration change resulting 
from the reaction with an antioxidant. The DPPH assay was believed to involve HAT 
reactions, but studies by Foti et al. (2004) and Litwinienko and Ingold (2004) suggested that 
an ET reaction is favored in the reaction between phenols having low pKa values and DPPH 
in strong hydrogen-bond-accepting solvents, like methanol and ethanol.  
The 15-lipoxygenase (15-LO) is an enzyme that catalyzes the stereospecific peroxidation of 
polyunsaturated fatty acids (PUFAs) and esters, which leads to the formation of 
hydroperoxides as well as  active radical intermediates that are involved in pathological 
processes in animals and man (Khairullina et al., 2011). Inhibition of 15-LO is of interest, as 
the enzyme has been proposed to have a role in the oxidation of LDL, a process which is 
believed to be an important step in the development of atherosclerosis and cardiovascular 
diseases (CVD) (Lyckander & Malterud, 1996; Schneider & Bucar, 2005). Furthermore, 15-
LO and their metabolites have been shown to be involved in a number of diseases such as 
cancer, psoriasis and diabetes (both type I and II) (Dobrian et al., 2011; Schneider & Bucar, 
2005). Thus, 15-LO inhibitors may have a beneficial impact on the treatment of these 
disorders. The 15-LO inhibitory effects are assessed in vitro by using soybean 15-LO 
(catalyst), with linoleic acid as the substrate (Schneider & Bucar, 2005). This is a fairly 
stable, inexpensive and easy method measured spectrophotometrically (234 nm), and a good 
correlation between inhibitory activity towards mammalian and soybean-derived enzymes 
has been reported (Lyckander & Malterud, 1992; Lyckander & Malterud, 1996).  
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Xanthine oxidase (XO) is an enzyme that catalyzes the oxidation of hypoxanthine to 
xanthine, and produces uric acid and superoxide. Overproduction of uric acid is associated 
with gout and kidney stones, while increased superoxide generation may lead to the 
formation of other ROS, which can initiate oxidative stress (Van Hoorn et al., 2002). The 
superoxide anion radical generated by XO is involved in a series of pathological disorders 
such as hepatitis, inflammation, ischemia-reperfusion, carcinogenesis as well as aging 
(Nguyen et al., 2004). Moreover, possible beneficial effects of XO-inhibitors as adjuncts in 
the management of severe Plasmodium falciparum malaria have been reported (Iwalokun et 
al., 2006). Allopurinol is a XO-inhibitor used clinically in the treatment of gout, but due to 
unwanted side effects and allergic reactions it is desirable with other alternatives (Nguyen et 
al., 2004). Inhibition of XO may therefore be a therapeutic strategy to combat gout and other 
diseases associated with oxidative stress. In this in vitro assay, XO from cow’s milk 
catalyzes the formation of uric acid and superoxide from the substrate hypoxanthine or 
xanthine, and the inhibition of XO can be measured spectrophotometrically around 290 nm. 
1.5.2 Į-Glucosidase inhibitory activity 
Diabetes mellitus is a group of metabolic diseases characterized by increased concentration 
of glucose in the blood (hyperglycaemia) resulting from defects in insulin secretion, insulin 
action, or both. Chronic hyperglycaemia is associated with long-term damage, dysfunction, 
and failure of various organs, especially eyes, kidneys, nerves, heart, and blood vessels 
(American Diabetes Association, 2006). According to WHO, 347 million people worldwide 
have diabetes, with an estimated 3.4 million deaths every year. Type II diabetes comprises 
90 % of the people with diabetes around the world, and is largely the result of excess body 
weight and physical inactivity. The WHO projects that diabetes will be the seventh leading 
cause of death globally in 2030, and the deaths will double between 2005 and 2030 (WHO, 
2013a) .  
One therapeutic approach to treat diabetes type II is to retard the absorption of glucose via 
inhibition of digestive enzymes such as Į-glucosidase and Į-amylase. Į-Glucosidase is a 
membrane bound enzyme located in the small intestine and also the key enzyme that 
catalyzes the final step in the digestive process of carbohydrates. Hence, Į-glucosidase 
facilitates the absorption of glucose by catalyzing the hydrolytic cleavage of non-absorbable 
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oligosaccharides (e.g. starch and sucrose) into absorbable monosaccharides in the small 
intestine (Kim et al., 2005; Kumar et al., 2011). Inhibitors of Į-glucosidase could therefore 
retard liberation of glucose from complex dietary carbohydrates and delay glucose 
absorption, thus suppressing postprandial hyperglycaemia. Currently, four Į-glucosidase 
inhibitors are used clinically to treat diabetes mellitus type II: acarbose, miglitol, voglibose 
and emiglitate. Of these, acarbose is by far the most prescribed drug (Van de Laar et al., 
2005). Although being effective by providing overall control of postprandial increase in 
blood glucose without causing any hypoglycaemia with a significant effect on the weight 
control, they usually cause bothersome gastrointestinal (GI) side effects such as flatulence, 
abdominal distension and diarrhea (Kumar & Sinha, 2012). These side effects, along with a 
stringent repetitive dosing regime at specified time intervals, lead to decreased patient 
compliance. More effective and safer Į-glucosidase inhibitors are therefore desirable, and 
many efforts have been made to identify natural Į-glucosidase inhibitors from plants as they 
may be lead compounds for treatment of diabetes (Gao et al., 2007; Kumar et al., 2011; 
Yoshikawa et al., 2002).  
1.5.3  Antimalarial activity  
Malaria is an infectious disease caused by Plasmodium parasites and is transmitted to 
humans via the bite of infected female Anopheles mosquitoes. According to the WHO, 3.4 
billion people were at risk of being infected with malaria in 2012 (WHO, 2013b). Every 
year, about 250 million people are affected by malaria resulting in 1 million deaths. Most 
vulnerable are children under the age of five and pregnant women. Five Plasmodium parasite 
species can cause malaria in humans, with Plasmodium falciparum being responsible for 
most of the fatal cases. Due to the development of resistance towards existing treatment 
regimens, there is an urgent need for new antimalarial drugs or alternative strategies with the 
final aim of reducing the burden of this disease (Mimche et al., 2011; WHO, 2010). 
Cerebral malaria (CM) is the most severe neurological complication of infection with P. 
falciparum malaria. The term ‘cerebral malaria’ implies the presence of neurological 
features, especially impaired consciousness. Hence, the clinical hallmark of CM is coma 
(Golenser et al., 2006; Idro et al., 2010). Mortality is high (15-20 %) and some surviving 
patients sustain brain injury that manifest as long-term neurocognitive impairments such as 
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agitation, psychosis, cerebellar ataxia, aphasia, seizures and impaired consciousness (from 
confusion to deep coma) (Mishra & Newton, 2009). The mechanisms behind these injuries 
and the pathogenesis of CM are incompletely understood and consequently a major 
hindrance to progress in CM research. Treatment of neurological complications is warranted, 
but trials conducted to date have not shown to improve the overall outcome of severe P. 
falciparum malaria. Combinations of adjuvant therapies (in addition to anti-parasitic drugs 
such as quinine or artemisinins) may be needed to improve the neurocognitive outcome (Idro 
et al., 2010; Mishra & Newton, 2009). It has therefore been suggested that the ultimate 
treatment of CM could possibly be a combination of an antimalarial and an 
immunomodulator as CM is considered to be an immunopathological event (Golenser et al., 
2006; Waknine-Grinberg et al., 2010). A plant-based immunomodulator displaying dual 
antimalarial and immunomodulatory mechanisms of action could therefore become ideal 
candidates for antimalarial drug development.   
1.5.4  Toxicity 
Despite the extensive use of phytomedicines/traditional medicines in Mali (see section 1.2) 
and other developing countries, very little is known about their chemical and biological 
qualities which also include the toxicity. While a few structured systematic analyses on 
beliefs about toxicity among traditional practitioners have been done (e.g. (Maiga et al., 
2005)), this is often not feasible due to lack of knowledge, infrastructure and resources 
among other factors. Simple preliminary toxicity studies of the plants used in traditional 
medicine is therefore an easy approach to obtain vital information to provide safe medicines 
to the Malian population. 
One simple and widely used test for toxicity is the “brine shrimp assay”. Larvae of the brine 
shrimp Artemia salina are incubated with test substance solutions or solvent only, and the 
percentage of dead larvae after a predefined time period is registered. This test has been in 
use for more than thirty years (Meyer et al., 1982). 
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2. Aims of the Thesis 
The ultimate goal for the Malian research project, of which this work is a part, is to provide 
efficient, non-toxic, available and affordable medicines to the population in Mali. The plants 
chosen for this thesis are Terminalia macroptera and Biophytum umbraculum. These two 
plants have been used in Mali in the treatment of a variety of diseases for long traditions, 
although the knowledge of their chemistry, toxicity and biological activities remains nearly 
unknown. It is therefore highly relevant to examine these features to ensure safe, efficient 
and cheap alternative medicinal products to the Malian people.  
The specific objectives of the study were: 
1. To perform an ethnopharmacological survey in order to obtain information on the 
traditional use of T. macroptera (Paper I).  
2. To isolate and characterize the chemical constituents of the Malian traditional 
medicinal plants, T. macroptera and B. umbraculum (Paper II and IV) 
3. To evaluate the in vitro antioxidant effects and other biological activities of T. 
macroptera and B. umbraculum extracts and their constituents (Paper II, III and IV). 
4. To investigate possible antimalarial and immunomodulating activities of B. 
umbraculum extracts and constituents (Paper V).
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3. Summary of Papers 
Paper I. Terminalia macroptera, its current medicinal use and future 
perspectives 
The aim of this paper was to identify the traditional use of the medicinal tree Terminalia 
macroptera. An ethnopharmacological investigation was carried out in the regions around 
Siby, Dogonland and Dioïla, Mali. The majority of the 78 traditional practitioners 
interviewed (86%) used T. macroptera in their practice, but the frequency of use varied 
between areas and between practitioners. More than 30 medical indications were reported. 
The most cited indications were sores and wounds, pain, cough, tuberculosis and hepatitis. 
The fidelity level among the traditional practitioners from the same area was calculated to 
compare results from different areas where the survey was performed. There was a high 
agreement among the traditional practitioners about the most frequently reported uses, 68% 
for the use against hepatitis in Dogonland, 38% for wounds in Siby and 28% for pain and 
rheumatism in Dioïla. The most commonly used tree parts were the stem bark and the roots, 
although all plant parts, even the parasitic Loranthus species growing on the tree, were 
employed. Most of the remedies were prepared as a decoction of the fresh tree material. 
Paper II. DPPH radical scavenging and xanthine oxidase inhibitory 
activity of Terminalia macroptera leaves 
The main objective of this study was to isolate and characterize the chemical composition of 
the leaves of T. macroptera. Cis-polyisoprene was the major non-polar constituent isolated 
from the DCM extract. The novel compound chebulic acid trimethyl ester, as well as the 
previously known ellagitannins corilagin, chebulagic acid, chebulinic acid, the flavonol-O-
glycosides rutin and narcissin, methyl gallate and shikimic acid were identified in the MeOH 
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crude extract. However, it is likely that chebulic acid trimethyl ester and methyl gallate are 
artifacts of chebulic acid and gallic acid, respectively. The DPPH radical scavenging and XO 
inhibiting effects of the plant extracts and its isolated compounds were also investigated. The 
MeOH crude extract was found to be a very potent DPPH radical scavenger and a moderate 
XO inhibitor (IC50 = 6.2 ± 0.4 and 52 ± 5 μg/mL, respectively), and these activities are 
probably due to the high content of ellagitannins. Chebulagic acid and corilagin showed very 
high radical scavenging activity (IC50 = 3.5 ± 0.1 and 4.3 ± 0.5 μM, respectively), while 
rutin and chebulagic acid were the most potent compounds towards XO. The antioxidant and 
radical scavenging properties of some of the substances identified in this study may 
contribute to explain the medical use of this tree in West Africa. 
Paper III. Į-Glucosidase inhibition, 15-lipoxygenase inhibition, and 
brine shrimp toxicity of extracts and isolated compounds from 
Terminalia macroptera leaves 
This paper is a continuation of the work on T. macroptera, and the Į-glucosidase- and 15-LO 
inhibiting effects as well as the toxicity of the plant extracts and its isolated compounds were 
investigated. In the enzyme inhibiting assays, all extracts showed high activity. The EtOAc 
extract showed strongest inhibition of both Į-glucosidase and 15-LO, with IC50 values of 
0.40 ± 0.02 and 23.2 ± 0.5 μg/mL, respectively. Among the isolated compounds, the 
ellagitannin chebulagic acid was the strongest inhibitor of both enzymes, with an IC50 value 
of 0.05 μM towards Į-glucosidase and 24.9 ± 0.4 μM towards 15-LO, which indicate that it 
is much more potent than the positive controls (acarbose: IC50 201 ± 28 μM towards Į-
glucosidase, quercetin: 93 ± 3 μM towards 15-LO). Although chebulagic acid may be the 
strongest inhibitor, the ellagitannin corilagin is present in much higher amounts (more than 
25 times, calculated from yield of substances) and may therefore be the most important 
contributor to the enzyme inhibitory activity of the extract. In addition, a simple brine shrimp 
toxicity test was carried out, and none of the extracts or the isolated compounds seemed to 
be toxic compared to the positive control podophyllotoxin. These results may substantiate 
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the fact that some traditional practitioners use T. macroptera leaves for the prevention or 
treatment of diabetes mellitus. 
Paper IV. Bioactive flavone-C-glucosides of the African medicinal 
plant Biophytum umbraculum
The aim of this study was to explore the chemistry and to evaluate the biological activities of 
the plant Biophytum umbraculum. Fractionation and purification of components from
extracts of the aerial parts of B. umbraculum followed by structural characterization by NMR 
resulted in the identification of three flavone-C-glycosides; cassiaoccidentalin A, isovitexin 
and isoorientin. Flavone-C-glycosides have not previously been reported in B. umbraculum. 
Whereas isovitexin and isoorientin are fairly common flavone glucosides, cassiaoccidentalin 
A is a very rare natural compound, only identified once before. Bioactivities were measured 
by DPPH radical scavenging and inhibition of the enzymes XO and 15-LO. The results of 
the antioxidant assays show higher activities in the EtOAc extract. This may be related to the 
bioactive flavone-C-glycosides isolated from this extract, especially isoorientin, as its 
structure is in good accord with previous structure-activity studies. Additional unidentified 
compounds may, however, be responsible for the XO inhibition. Thus, it was concluded that 
B. umbraculum might be a valuable source of flavone C-glycosides. 
Paper V. Biophytum umbraculum as adjuvant treatment of cerebral 
malaria 
In this paper, the antimalarial and the immunomodulating activities of B. umbraculum
extracts and isolated compounds were investigated. Our ethnopharmacological investigations 
in Mali revealed that more than 50 % of the traditional practitioners used B. umbraculum
against cerebral malaria. Two CM-related in vitro assays were chosen to assess the possible 
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immunomodulating activity. The plant extracts showed a complement inhibiting activity as 
well as dose-dependent inhibition of NO release from activated macrophages. The EtOAc 
extract was the most active in both assays. The EtOAc extract showed moderate antimalarial 
activity against the erythrocyte stages of Plasmodium falciparum strain NF54 and K1 (mean 
IC50 = 6.7 μg/mL and 5.6 μg/mL, respectively). Our results are comparable to the results 
reported for Artemisia annua (IC50 = 6.7 μg/mL), which is the source of artemisinins, the 
clinically used antimalarial drug. However, the isolated flavone-C-glycosides were inactive 
in all of the assays. The nature of the active compounds is thus so far unknown, and although 
the results are interesting, further investigations  and clinical studies are needed before one 
can conclude whether B. umbraculum should be used as adjuvant treatment of cerebral 
malaria or not. 
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4. Results and Discussion
4.1 Ethnopharmacological research 
Ethnopharmacology as a specifically designated field of research has a relatively short 
history, and the term was first used in 1967 in a book about hallucinogens. Nowadays, the 
term is more broadly defined by the statement “The observation, identification, description 
and experimental investigation of the ingredients and the effects of the ingredients and the 
effects of such indigenous drugs is a truly interdisciplinary field of research which is very 
important in the study of traditional medicine. Ethnopharmacology is here defined as the 
interdisciplinary scientific exploration of biologically active agents traditionally 
employed or observed by man” (Heinrich & Gibbons, 2001). Seeing that as much as 75 % 
of the Malian population relies on traditional medicine, it is highly important to do 
ethnopharmacological research to improve this type of medicines, in order to give a better 
life to the local people. This is particularly vital in remote regions where the availability of 
conventional medicine is limited because of poverty. Although the use of traditional 
medicine is well established and has very long traditions, only a small portion of information 
about these medicines has been documented scientifically. One of the reasons could be that 
since most of the people in Mali are illiterate, most of the information is not written down, 
but has been passed on orally for generations. And because this information is often held by 
the elderly, there is an urgent need to obtain and document valuable information on useful 
medicinal plants. In the aspect of bioprospecting and drug discovery it is also worth 
mentioning that many important drugs on the market today originate from plants with a long 
history of ethnopharmacological use. Examples include opiates, quinine, artemisinin and 
digitalis glycosides (DeSmet, 1997; Fabricant & Farnsworth, 2001; Heinrich & Gibbons, 
2001).  
In Paper I we investigated the traditional use of Terminalia macroptera in three different 
areas in Mali (Siby, Dioïla and Dogonland). We found that the traditional practitioners 
usually use a hot water decoction of the stem bark or the root. The plant was in most cases 
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administered orally or used for washing the body or the infected area. 86 % of the 78 
practitioners interviewed used the plant to cover over 30 indications. The most frequent 
indications are wounds, infections, pain, cough, tuberculosis and hepatitis. Two different 
surveys performed during the years 1998-2002 reported T. macroptera as a wound healing 
remedy in the Bamako region (Diallo et al., 2002) and in the district of Bandiagara 
(Inngjerdingen et al., 2004) of Mali. In various surveys carried out in Africa (mainly West 
Africa), it has been reported that this plant is used to treat peptic ulcer, malaria, liver 
disorders, cough and various GI disorders (see section 1.3.1). It seems to be some extent of 
consensus between the indications covered in our survey and the indications reported in 
other West African countries. The use of the plant for wound healing seems widespread, so 
the plant might be antibacterial and perhaps astringent. This could be related to the presence 
of ellagitannins (see section 1.4.2.1). 
Figure 4.1: Map of Mali. The places where the ethnopharmacological surveys were carried out are 
underlined (Fitzgerald, 2013).
The traditional use of Biophytum umbraculum was investigated in Bamako, Siby and Dioïla 
(Paper V). Most of the practitioners (90 %) used the plant in their practice, and 50 % of the 
34 interviewed practitioners used B. umbraculum against cerebral malaria. Other common 
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indications were various GI disorders. The aerial parts of the herb are usually prepared as a 
powder preparation or hot water decoction. Patients suffering from cerebral malaria are often 
in poor general condition (e.g. convulsions, seizures, and coma) which make it difficult to 
take the medicine orally, this could explain why the plant is usually prepared as a powder 
preparation for topical administration. These findings were similar to the results from the 
survey conducted by Grønhaug et al. (2008) where cerebral malaria was the main indication 
for B. umbraculum (58 %), while different types of pain and wounds were less common 
indications. In the survey carried out in the Bamako region by Diallo et al. (2002), B. 
umbraculum was identified as a wound healing plant. A limited survey conducted in Sikasso, 
Dioïla, Kolokani and Blendio, Mali, revealed that the plant was used against malaria, 
wounds and stomachache (Inngjerdingen et al., 2006). The traditional practitioners’ 
consensus for the main indication is fairly high, and this supports the traditional use of B. 
umbraculum as a remedy to treat cerebral malaria. 
Although being used as traditional medicines by many practitioners, these plants have 
undergone very limited chemical and/or pharmacological investigations. And the fact that 
traditional practitioners from regions that differ in geographic and ethnographic 
characteristics report the same plants for the treatment of the similar diseases further 
supports the medicinal use of these plants. It is therefore of great interest and relevance to 
study the structure and biological activities of these plants. Polar and semipolar substances of 
low molecular weight like tannins, flavonoids and other polyphenols were of particular 
interest as high molecular weight substances like polysaccharides have already been 
examined for e.g. wound healing properties and immunomodulating properties. 
4.2 Extraction and isolation procedures 
The studied plants were obtained fresh and then air-dried, milled and pulverized at DMT, 
Mali before shipping to Oslo, Norway. In general, the dried plant material was initially 
extracted with dichloromethane (DCM) followed by methanol (MeOH) in a Soxhlet 
apparatus or by maceration at room temperature (RT). The obtained crude extracts were then 
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extracted successively with solvents of increasing polarity (Figure 4.2). A rough separation 
of constituents with varying polarity is obtained with this procedure. Size exclusion 
chromatography (SEC) was the principle utilized to separate low and high molecular weight 
constituents. Sephadex LH-20 was chosen due to its high selectivity and adsorption effects 
for aromatic compounds, since most of the compounds studied in this work were of that 
kind. However, a drawback with this property is that it can lead to potential failure of size-
based separation. Nevertheless, SEC is a low resolution chromatography as it does not 
discern similar species very well, so the chromatographic techniques chosen for further 
fractionation and purification was mainly based on polarity, pattern in NMR spectra and 
weight of the fractions. Reverse phase (RP) and normal phase (NP) silica gel were primarily 
used to separate compounds with different polarity. Additionally, preparative high 
performance liquid chromatography (HPLC) with a RP C-18 column was an effective 
method to obtain pure compounds. The pure compounds were obtained by collection of the 
peaks detected by a UV-detector. After a chromatographic run, the collected fractions were 
combined as indicated by thin layer chromatography (TLC). Spots were visualized by 
ultraviolet (UV) irradiation (254 nm and 366 nm), by spraying with Ce(SO4)2 in aqueous 
sulfuric acid followed by heating to detect organic compounds, or by spraying with 
methanolic DPPH  radical solution to spot radical scavenging activity. 1H-NMR and 13C-
NMR spectroscopy was regularly carried out to get an indication of the chemical 
composition of the extracts and the purified fractions. 
Figure 4.2: Illustration of the general extraction procedure.
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Due to lack of material for biological studies, a second batch of B. umbraculum (Paper IV 
and V) was subjected to Soxhlet extraction to yield DCM and MeOH crude extracts, and 
subsequent ethyl acetate (EtOAc), butanol (BuOH) and aqueous fractions of the MeOH 
crude extract. Ideally, the second batch should have been extracted at RT as done with the 
first batch where the pure compounds originate from, since the Soxhlet system could cause 
thermal degradation of compounds. However, the NMR spectra were compared and no 
noteworthy dissimilarities were found. 
  
4.3 Chemical characterization 
T. macroptera leaves were found to contain a variety of ellagitannins and flavonoids (Paper 
II). Totally, nine compounds were isolated and identified; three ellagitannins (corilagin, 
chebulagic acid and chebulinic acid), two flavonol-O-glycosides (rutin and narcissin), rubber 
(poly-cis-isoprene), chebulagic acid trimethyl ester, methyl gallate and shikimic acid (Figure 
4.3). Their structures were elucidated on the basis of NMR spectroscopy data. Optical 
rotation was also recorded as part of the characterization of novel compounds. Chebulic acid 
trimethyl ester was identified as a new chemical compound. Corilagin was found to be the 
main compound in the BuOH extract, and its NMR resonances were clearly visible in the 1H-
NMR spectrum of both the MeOH as well as the BuOH extract. Corilagin is a fairly rare 
ellagitannin which has obtained its name from the tree Caesalpinia coriaria (Leguminosae) 
(Schmidt & Lademann, 1951). The pods of this tree are a very good source of tannins 
(Pérez-Tello & Quintana-Hernéndez, 1995). Corilagin has, as far as we know, not been 
reported in T. macroptera previously, but has formerly been isolated from other Terminalia
species. The other two ellagitannins, chebulagic acid and chebulinic acid, are also found in 
other Terminalia species (Pfundstein et al., 2010). The flavonol-O-glycosides rutin and 
narcissin have not previously been reported from the leaves of T. macroptera, but have 
previously been found in the flowers (Nongonierma et al., 1990). Narcissin is quite rare as 
compared with the very common flavonoid rutin. The biosynthetic precursor for flavonoids 
and hydrolyzable tannins, shikimic acid, was identified by comparison with published NMR 
data, as was methyl gallate, which is the methyl ester of gallic acid and possibly an artifact 
formed during extraction.
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Figure 4.3: Chemical structures of the isolated compounds from Terminalia macroptera.
The NMR spectral data of chebulic acid trimethyl ester indicated a compound with three 
carboxyl groups, a carbonyl, three methyl esters and an aromatic ring with one proton and 
three hydroxyl groups. Assignments were confirmed by 2D-NMR techniques (COSY, 
HSQC and HMBC). Comparison with published data for chebulic acid (Ding et al., 2000; 
Lee et al., 2007) and chebulic acid triethyl ester (Yang et al., 2008) led to the identification 
of chebulic acid trimethyl ester. The main differences in the 1H NMR spectra were the three 
singlets (3.54 – 3.68 ppm) for the three methoxyl groups of chebulic trimethyl ester lacking 
in the NMR spectrum of chebulic acid, whilst in the spectrum of chebulic acid triethyl ester,  
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Table 4.1: Comparison of 1H NMR data of chebulic acid trimethyl ester with published data 
Carbon Chebulic acid trimethyl ester Chebulic acid triethyl ester  Chebulic acid 
No. (300 MHz, (CD3)2CO)a  (Yang et al. 2008) (Ding et al. 2000) 
 įH (J, Hz) įH (J, Hz) įH (J, Hz) 
1 - - Ͳ
2 - - Ͳ
3 5.27 (1H, d, 1.2) 5.23 (1H, d, 0.9) 5.28 (1H, d, 0.8) 
4 3.90 (1H, dd, 1.2, 7.9) 3.88 (1H, dd, 0.9, 8.4) 3.90 ( 1H, dd, 0.8, 8.4) 
5 - - - 
6 - - - 
7 - - - 
8 7.12 (1H, s) 7.11 (1H, s) 7.09 (1H, s) 
9 - - - 
10 - - - 
11 3.25 (1H, ddd, 4.8, 8.0, 10.0) 3.21 (1H, ddd, 4.8, 8.4, 9.9) 3.15 (1H, ddd, 4.4, 8.4, 10.4) 
12a 2.87 (1H, dd, 10.0, 16.9) 2.86 (1H, dd, 9.9, 16.8) 2.90 (1H, dd, 10.4, 17.2) 
12b 2.52 (1H, dd, 4.7, 16.9) 2.47 (1H, dd, 4.8, 16.8) 2.40 (1H, dd, 17.2, 4.4) 
13 - - - 
14 - - Ͳ
15 - - Ͳ
13 OCH3 3.54 (3H, s) b b
14 OCH3 3.68 (3H, s) b b
15 OCH3 3.60 (3H, s) b b
a Assignments were confirmed by COSY, HSQC and HMBC experiments. 
b Not applicable  
occurred as quartets (3.97 – 4.17 ppm) and triplets (1.05 – 1.23 ppm) for the CH2 and CH3 in 
the ethyl groups, respectively, were observed (Table 4.1 and 4.2). Although being a novel 
compound not previously reported in scientific literature, it is likely that chebulic acid 
trimethyl ester is an artifact formed by esterification between methanol and COOH groups of 
chebulic acid during extraction. Analogously, Terminalia chebula extraction with ethanol 
yielded chebulic acid triethyl ester (Yang et al., 2008). Additionally, chebulic acid has also 
been reported from T. chebula (Lee et al., 2007). Ellagitannins with a 1C4-glucopyranose 
core and a unique chebuloyl group, such as chebulagic acid and chebulinic acid, and their 
co-occurrence with punicalagin (a fairly rare tannin reported in T. macroptera (Silva et al., 
2000)) and punicalin is a chemotaxonomic feature of the Terminalia species (Yoshida et al., 
2010). These so-called chebulic ellagitannins belong to a relatively small group of 
metabolites of the hexahydroxydiphenoyl ester class in which one of the aromatic rings has 
undergone hydrolytic cleavage to generate one or more additional carboxylate groups 
(Figure 4.4) (Haslam, 1998; Pfundstein et al., 2010). Strictly speaking, chebulinic acid is a  
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Table 4.2: Comparison of 13C NMR data of chebulic acid trimethyl ester with published data 
Carbon Chebulic acid trimethyl ester Chebulic acid  Chebulic acid 
No. (300 MHz, (CD3)2CO)a  (Gang et al. 2001)  (Lee et al. 2007) 
  įC įC įC
1 163.87 166.87 163.3 
2 - - - 
3 77.69 78.76 76.4 
4 36.68 37.33 35.6 
5 143.29 143.98 142.7 
6 139.00 140.58 138.7 
7 145.99 146.66 145.3 
8 108.99 109.33 107.6 
9 116.95 116.29 114.8 
10 117.07 118.12 116.6 
11 44.76 45.49 43.7 
12 34.55 35.23 34.2 
13 172.39 175.55 172.9 
14 173.97 176.97 174.4 
15 170.57 172.84 170.9 
13 OCH3 51.85 b b
14 OCH3 52.46 b b
15 OCH3 53.00 b b
a Assignments were confirmed by COSY, HSQC and HMBC experiments. 
b Not applicable  
gallotannin, although it is closely associated with the ellagitannins (and chebulagic acid, 
which may be characterized as dehydrochebulinic acid) (Haworth, 1961), and is nowadays 
regarded as a chebulic ellagitannin (Pfundstein et al., 2010). 
Figure 4.4: The putative biogenetic pathway to “ring opened” HHDP ester; chebulic acid, a 
component of chebulinic acid (Haslam, 1998) and chebulagic acid. 
During the chemical characterization of Biophytum umbraculum, the herb was found to 
contain high amounts of flavonoids (Paper IV). The three flavone-C-glycosides 
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cassiaoccidentalin A, isovitexin and isoorientin were isolated from the EtOAc extract of B. 
umbraculum (Figure 4.5). Their structures were established on the basis of spectroscopic 
data. Cassiaoccidentalin A turned out to be the main compound in the EtOAc extract, and 
traces of it are also seen in the BuOH extract, as evidenced by NMR. Cassiaoccidentalin A is 
a very rare flavone glycoside which has only been identified once before, in Cassia 
occidentalis (Hatano et al., 1999). Interestingly, C. occidentalis happens to be the principal 
plant accounting for 62 % (together with 32 % Lippia chevalierii and 6 % Spilanthes 
oleracea) of the phytoremedy Malarial (Figure 4.6), one of the ITMs developed by the DMT 
for the treatment of malaria and recognized as an essential and effective medicine in Mali 
(Diallo & Paulsen, 2000). It is therefore highly relevant so see if cassiaoccidentalin A could 
be one of the components contributing to the antimalarial activity of Malarial. The flavone 
glucosides isovitexin and isoorientin are more common and have previously been found in 
another Biophytum species, Biophytum sensitivum (Bharati & Sahu, 2012). 
Figure 4.5: Chemical structures of the flavone-C-glycosides isolated from Biophytum umbraculum.
Figure 4.6: The improved traditional medicine (ITM) Malarial (Photo: A.T. Pham). 
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4.4 Biological activities 
4.4.1  Antioxidant activity  
The antioxidant activity of the plant extracts and isolated compounds was evaluated in Paper 
II, III and IV. Three different methods were employed because one single method is not 
sufficient to evaluate the total antioxidant activity due to the complexity of phytochemicals 
as well as of oxidative processes (Wangensteen et al., 2004); scavenging of DPPH radical, 
inhibition of 15-LO and inhibition of XO. The results are summarized in Table 4.3 and 4.4. 
It was observed that the lipophilic crude extracts were generally inactive as antioxidants, in 
contrast to the more polar extracts which possessed high or moderate antioxidant activities. 
In all three bioassays, the EtOAc extracts were, in particular, the most potent of all the 
extracts, whereas the aqueous residues were the least potent. This might suggest that ethyl 
acetate has a higher selectivity for phenolics and antioxidant components. Chyau et al. 
(2002) reported similar results from their work on Terminalia catappa leaves, as did 
Jayaprakasha et al. (2008) on their studies on extraction efficiency of different solvents on 
the antioxidant capacities of pummelo and navel oranges. Although the DCM extract of T. 
macroptera was not tested for XO and 15-LO inhibitory activity due to low solubility or 
precipitation in the test systems, it would probably be inactive as it was inactive in the DPPH 
radical scavenging assay (Table 4.3). Moreover, it was observed that the number of OH 
groups is important for radical scavenging activity. Consequently, monophenolic compounds 
were generally weaker as antioxidants compared to polyphenols. In Paper II, the DPPH 
radical scavenging activity of the flavonol glycosides rutin and narcissin (IC50 values 22 ± 2 
μM and > 83 μM, respectively) were studied. The lower IC50 value of rutin indicates that the 
3’,4’-dihydroxy structural element is important for radical scavenging activity. The same 
phenomenon was seen with the flavone-C-glycosides isovitexin and isoorientin (IC50 values 
96 ± 3.6 μM and 18.1 ± 1.1 μM, respectively) in Paper IV. Our results are consistent with 
previous reports on antioxidant activity of flavonoids being dependent on the number and 
position of substituted OH groups. (Farkas et al., 2004; Heim et al., 2002; Selloum et al., 
2001). 
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In Paper III and IV, the inhibitory potency of the plant extracts and its isolated constituents 
towards peroxidation of linoleic acid catalysed by soybean 15-LO was studied. Extracts of 
both T. macroptera and B. umbraculum were active as inhibitors of 15-LO, but extracts of T. 
macroptera showed generally higher activity, on the same order as the positive control, 
quercetin (IC50 = 33.4 ± 0.3 μg/mL). The high content of ellagitannins and flavonoids may 
explain the results, seeing that some of these showed considerably higher effects than the 
positive control, as was the case with chebulagic acid, corilagin and narcissin. Interestingly, 
in our results, narcissin was more potent than rutin in 15-LO inhibition, as opposed to the 
results by Robak et al. (1988), who reported narcissin to be inactive. The deviating results 
may be due to differences in the experimental setup or to different enzyme sources. The 
reversed activity of rutin and narcissin in the DPPH versus the 15-LO assays might seem 
unexpected. It has, however, been shown that DPPH scavenging and 15-LO inhibition are 
not necessarily correlated (Malterud et al., 1993).  
The apparent 15-LO inhibitory activity of narcissin is probably explained by other factors 
than the C2-C3 double bond in conjunction with a 4-oxo function in the C-ring alone. This 
reversal of activity was not seen in the case of isovitexin and isoorientin, where isoorientin 
was a stronger antioxidant in all of the three antioxidant tests.  
The inhibitory effects towards the superoxide-producing enzyme XO from cow’s milk were 
investigated. T. macroptera crude extract was moderately active as XO inhibitor (Paper II). 
Among the isolated compounds, only rutin and chebulagic acid possessed enzyme inhibitory 
activity, while the remaining compounds were inactive at the highest measured 
concentration. However, all samples showed lower activities than the reference compound, 
quercetin. Rutin has previously been reported to be a XO inhibitor (Choi et al., 2002), in 
good accord with our findings. B. umbraculum showed moderate activity towards XO (Paper 
IV). This activity cannot be attributable to any of the isolated compounds, suggesting that the 
EtOAc extract may contain additional unidentified XO inhibitors. Among the isolated 
flavone-C-glycosides, isoorientin was the most potent antioxidant. Cotelle et al. (1996) have 
previously reported that flavones with both a 7-OH substitution and a catechol (or 3’,4’,5’- 
pyrogallol) function on the B-ring, are the most effective inhibitors of XO, and our findings 
seems to concur with the suggested theory. Due to lack of material, chebulinic acid was not 
tested for antioxidant activity at all. 
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Table 4.3: Antioxidant activity of T. macroptera and B. umbraculum extracts tested by DPPH  
radical scavenging, 15-LO inhibition and XO inhibition. IC50 values ± S.D. (in μg/mL) are 
shown. 
Extract DPPH    XO 15-LO 
          
Terminalia macroptera:   
DCM crude extract Inactive   a a
MeOH crude extract 6.2 ± 0.4   52 ц 5 27.9 ц 1.5 
EtOAc extract 3.7 ± 0.2   26 ц 3 23.2 ц 0.5 
BuOH extract 6.5 ± 0.4   64 ц 8 30.0 ц 2.3 
Aqueous residue 12.4 ± 0.6   146 ц 15 a
Quercetin (positive control) 3.0 ± 0.2   0.6 ± 0.1 28.1 ц 0.8 
Biophytum umbraculum: 
DCM crude extract > 167 > 167 > 167 
MeOH crude extract 13.4 ± 0.6 59.7 ± 6.1 68.9 ± 5.0 
EtOAc extract 6.8 ± 0.6 ca. 21 43.0 ± 3.6 
BuOH extract 12.5 ± 1.9 102.6 ± 5.6 53.4 ± 2.1 
Aqueous residue 29.8 ± 3.5   > 167 > 167 
Quercetin (positive control) 4.4 ± 0.4   2.33 ± 0.09 33.4 ц 0.3 
a Not tested           
          
Table 4.4: Antioxidant activity of isolated compounds from T. macroptera and B. umbraculum  
tested by DPPH radical scavenging, 15-LO inhibition and XO inhibition. IC50 values ± S.D. (in μM) 
are shown. 
Compound DPPH    XO   15-LO 
            
Terminalia macroptera:           
Chebulic acid trimethyl ester 11.8 ц 1.0   > 419   85.3 ц 1.2 
Methyl gallate 12.1 ц 0.4   > 83   96 ц 5 
Shikimic acid 529 ц 46   > 958   > 957 
Corilagin 4.3 ц 0.5   > 83   41 ц 4 
Rutin 22 ц 2   ca. 40   97 ц 7 
Narcissin > 83   > 83   45 ц 2 
Chebulagic acid 3.5 ц 0.1   53 ц 8   24.9 ц 0.4 
Chebulinic acid a   a   a
Quercetin (positive control) 9.4 ц 0.6   1.9 ц 0.4   93 ц 3 
            
Biophytum umbraculum:           
Cassiaoccidentalin A > 167   149.5 ц 7.4   99.9 ц 2.5 
Isovitexin 96.0 ц 3.6   > 167   107.1 ц 2.1 
Isoorientin 18.1 ц 1.1   117.2 ц 13.5   86.4 ц 0.5 
Quercetin (positive control) 13.7 ± 1.3   7.7 ± 0.3   110.6 ц 1.0 
a Not tested 
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4.4.2 Į-Glucosidase inhibitory activity 
In Paper III, Terminalia macroptera extracts and components were assessed for their 
abilities to inhibit Į-glucosidase from yeast, since diabetes was one of the indications 
mentioned in our ethnopharmacological survey carried out previously (Paper I). All the 
tested extracts were strong inhibitors of Į-glucosidase, more than 250 times stronger than the 
positive control acarbose, which is a widely used antidiabetic drug that is used clinically 
today. The lipophilic DCM extract was not tested due to low solubility. The observed Į-
glucosidase inhibitory activity may be ascribed to the high content of polyphenols, which 
have been shown to inhibit the activities of digestive enzymes due to their ability to bind to 
proteins (McDougall & Stewart, 2005). Previous studies have shown that ellagitannins 
possess Į-glucosidase inhibitory activity, and it has been proposed that an increasing number 
of galloyl units in the molecule might lead to an increase in inhibitory activity (Omar et al., 
2012; Toda et al., 2000). However, it is unclear whether only the number of free galloyl 
groups is responsible for the activity, or that the position of HHDP or galloyl substitution 
might also affect the activity (Toda et al., 2000). Based on our results, we cannot draw any 
conclusions about the relevance of the galloyl- and HHDP groups for the inhibitory activity 
because only corilagin and chebulagic acid was tested, and both of them are comprised of 
one galloyl and one HHDP group. In chebulinic acid, the HDDP group has been replaced by 
two galloyl groups, and it has previously been reported that chebulinic acid is a slightly 
better inhibitor of Į-glucosidase than chebulagic acid (Gao et al., 2007).  Since chebulagic 
acid is 50 times more active than corilagin, the chebuloyl group would seem to be important 
for inhibition of this enzyme, while the relative importance of galloyl and HHDP groups 
remains unclear. It should be noted that inhibitory activity may vary widely between Į-
glucosidases from different sources (Gao et al., 2008). Further investigations are needed to 
follow this up. Although being less active, corilagin is present in much higher amounts and 
may therefore be more responsible for the very high inhibitory activity of the extract. Ryu et 
al. (2010) have reported that flavonoids have shown high Į-glucosidase inhibitory activity, 
and structure-activity relationship studies by Tadera et al. (2006) revealed that the inhibitory 
activity of flavonoids increased considerably with an increase in the number of the hydroxyl 
groups on the B-ring, unsaturated C-ring, hydroxylation at the 3 and 5 positions of the 
flavone skeleton, 2,3-double bond and 4-CO in the C-ring. Rutin, which is the most potent 
flavonol glycoside in our studies, has many of the structural features mentioned above, and 
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that probably explains its high inhibitory activity towards Į-glucosidase, in contrast to the 
less active narcissin, which lacks an OH group on the B-ring compared to rutin. 
Even though T. macroptera seem to be a good potential source of highly active Į-
glucosidase inhibitors, additional in vitro and in vivo testing is needed, especially since yeast 
Į-glucosidase is distinct from the small intestinal Į-glucosidase. It would therefore be 
relevant to first test against rat small intestinal Į-glucosidases and the closely related 
digestive enzyme Į-amylase for inhibitory activity. Furthermore, the potential to reduce 
glucose concentration postprandial in patients with type II diabetes should be investigated in 
clinical studies. 
4.4.3  Antimalarial activity 
4.4.3.1 In vitro antiplasmodium assay 
Extracts and purified compounds from Biophytum  umbraculum were screened against two 
strains of Plasmodium falciparum, the chloroquine-sensitive strain NF54 and the multidrug 
resistant strain K1 (Paper V). Human erythrocytes served as host cells. The highest measured 
concentration was 10 μg/mL, since IC50 values above this concentration were considered 
inactive. Of the semipolar extracts, it was only the EtOAc extract which possessed a 
moderate antiplasmodial activity against both the NF54 and the K1 strains of P. falciparum 
(IC50 = 6.7 and 5.6 μg/mL, respectively). The IC50 values are comparable to the IC50 value 
(3.9 μg/mL) reported for the ethanolic extracts of Artemisia annua (Phillipson & Wright, 
1991; Vonthron-Senecheau et al., 2003) and other active plant extracts (Abiodun et al., 2011; 
Bah et al., 2007; Irungu et al., 2007; Ramazani et al., 2010). These results are interesting and 
warrant further investigations, since traditional medicines have been used to treat malaria 
since ancient times, and are the source of two main groups (artemisinins and quinine 
derivatives, from A. annua and Cinchona back, respectively) of modern antimalarial drugs 
(Irungu et al., 2007). The lipophilic DCM extract showed activity against the K1 strain only 
(IC50 = 7.4 μg/mL). All the isolated flavone-C-glycosides, including cassiaoccidentalin A, 
were inactive towards both strains. The observed antiplasmodial activity of the EtOAc 
extract is therefore likely to come from other unidentified substances, or possibly by 
synergistic action. 
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Even though there have been some reports on the antiplasmodial activity of flavonoids 
(Andayi et al., 2006; Kraft et al., 2003), the observed effects are usually low compared to the 
positive controls which are often artemisinins or chloroquine. The most active antimalarial 
natural products are generally alkaloids, polyacetylenes, xanthones, quinones, polyketides or 
terpenoids (Nogueira & Lopes, 2011). Searches through scientific databases such as 
SciFinder and Web of Science did not show any of these classes of substances in B. 
umbraculum or in other Biophytum species.  
There are several ways to measure the in vitro antimalarial activity. The method used is 
standard [3H]hypoxanthine incorporation assay. It is the most commonly used method in 
well-equipped laboratories, and the advantage is high reproducibility. However, the handling 
of radioactive material is costly, hazardous and requires the availability of trained staff as 
well as appropriate technology. A potential alternative, especially in resource-limited 
environments, is the novel aldolase ELISA assay, which is highly reproducible, less 
hazardous (involves no radioactivity) and required little and cheap technical equipment. It is 
a userfriendly assay and can be operated by relatively unskilled personnel (Tritten et al., 
2009). 
4.4.3.2 Immunomodulating activity 
In regard to the possible immunomodulating activities of B. umbraculum, the extracts and 
isolated compounds were tested in two immunological in vitro test systems (Paper V). The 
two systems focus on different parts of the immune system, the complement system and the 
macrophages, which both are parts of the innate immune system. Owing to the fact that 
cerebral malaria (CM) can be associated with a high complement activation and 
inflammation, complement inhibitory and anti-inflammatory agents may therefore be useful 
in the treatment of this disease (Goto & Sanchez, 2013; Mimche et al., 2011; Waknine-
Grinberg et al., 2010). 
All of the semipolar extracts were shown to be highly active complement inhibitors of the 
classical pathway, with the EtOAc extract as the most potent inhibitor (ICH50 = 5 μg/mL). It 
is twelve times more active than well-known complement inhibitor, rosmarinic acid (ICH50 = 
64 μg/mL) (Sahu et al., 1999). Despite the high complement inhibition observed for the 
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EtOAc extract, the major isolated flavone-C-glycosides, isovitexin and isoorientin, exhibited 
weak complement activating properties. Previous studies have shown that flavone aglycones 
and flavone-O-glycosides have anti-complementary activity (Pieroni et al., 2000). Isovitexin 
and isoorientin account for only 2 % of the extract, and it is unlikely that they would have a 
high impact on the activity of the EtOAc extract. Possible synergistic effect between some of 
the components or other highly active, so far unidentified components with higher impact, 
may explain the complement inhibitory effects presented. The DCM extract displayed both 
inhibiting and activating properties indicating that it contains both activating and inhibiting 
constituents. 
The EtOAc extract gave the highest inhibition of nitric oxide (NO) production in RAW 
264.7 macrophages activated by lipopolysaccharide (LPS). The potency order of the extracts 
is the same as in the complement assay; EtOAc > BuOH > MeOH. And somewhat similarly, 
all of the isolated compounds were inactive as well, and therefore it is anticipated that other, 
so far unidentified, substances are responsible for the anti-inflammatory activity observed. 
The complement inhibitory effects as well as the ability to inhibit NO production by 
activated macrophages may have the potential to lead to improved outcomes in CM.  
Although in vitro anti-inflammatory activity may not be clinically relevant in vivo, these 
findings merit additional research to see if B. umbraculum could be used in adjuvant therapy 
together with an antimalarial medicine to treat CM.
4.4.4  Toxicity 
The brine shrimp lethality assay is a simple, effective and inexpensive method to screen pure 
compounds and plant extracts for potential toxic activity. In addition, it has the advantage 
over cytotoxicity assays of not requiring higher animal serum, and is faster and cheaper. In 
Paper III, tested compounds and extracts of T. macroptera showed low toxicity (LC50 > 200 
μM for pure compounds and LC50 > 100 μg/mL for extracts) against brine shrimp larvae 
compared to the positive control, podophyllotoxin (which had 87 % lethality at 50 μg/mL). 
According to Conrad et al. (2001b), two other tannins, 2,3-O-(S)-hexahydroxydiphenoyl-D-
glucose and punicacortein C, isolated from T. macroptera bark were found to be cytotoxic 
       37
towards 5637 cells (human primary bladder carcinoma). The extracts were, however, not 
tested. 
B. umbraculum extracts were tested for cytotoxic effects against RAW 264.7 cells using the 
MTS-assay in Paper V. The highest measured concentration was 50 μg/mL. The DCM 
extract showed cytoxicity (37 % cell viability compared to LPS control at T = 130 min) and 
was therefore not included in the NO-assay. Moreover, the highest EtOAc concentration 
showed some cytotoxicity (69 % cell viability at T = 130 min) as well, but not enough to 
explain the decrease in NO production. B. umbraculum has not been investigated for toxicity 
before, but previous studies on B. sensitivum have shown cytotoxicity and inhibition of NO 
production as well (Guruvayoorappan & Kuttan, 2007). 
Maiga et al. (2005) conducted a survey of toxic plants on the market in the district of 
Bamako, Mali. A total of 106 traditional practitioners were interviewed and 19 plants were 
reckoned to be toxic. Neither T. macroptera nor B. umbraculum were among the possible 
toxic plants mentioned. Interestingly, the plants used to treat the toxic effects were plants 
known to contain tannins or belong to families containing tannins. Tannins in food may act 
as digestion inhibitors with the resultant suppression of uptake from the GI tract (Aganga & 
Mosase, 2001). Guiera senegalensis, which comes from the same family as T. macroptera, 
Combretaceae, is one of the most frequently used plants by the traditional practitioners for 
intoxication. T. macroptera should perhaps be investigated for possible detoxification effects 
due to its tannin content, as diarrhea, which is one of the common adverse signs of 
intoxication, is also one of the indications reported in previous ethnopharmacological studies 
of T. macroptera.  
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5. Conclusions  
As modern health care services are not adequate for the majority of the Malian population, 
and most people have limited economic means to buy Western conventional medicine, 
traditional medicine prepared from plants remains the most popular medicine in solving 
health problems in Mali. Although being used by 75 % of the population, the knowledge of 
the plants’ chemistry, toxicity and biological activities is close to unknown. This study 
provides a better understanding of two of the plants, Terminalia macroptera and Biophytum 
umbraculum, with the main focus on the phenolic compounds and the antioxidant potential, 
as the health benefits of antioxidants have acquired considerable interest in recent years. 
Most of the semipolar extracts displayed high antioxidant activity, and this activity is 
attributable to the presence of tannins and flavonoids. In addition to antioxidant activity, 
strong Į-glucosidase inhibitory activity was seen for T. macroptera, and significant 
antimalarial and immunomodulating activities were observed for B. umbraculum. Even 
though the results are promising and may to some extent give a rationale for the traditional 
use, they are derived from in vitro experiments and need to be followed up with in vivo tests 
and clinical trials. This should be subjects for future research. 
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Abstract: Three flavone-C-glycosides—cassiaoccidentalin A (1), isovitexin (2) and 
isoorientin (3)—were isolated from the ethyl acetate (EtOAc) soluble fraction of the 
methanol crude extract of the African medicinal plant Biophytum umbraculum, This is the 
first report of these compounds in this plant. All compounds were identified by 
spectroscopic analysis and comparison with published data. Isoorientin (3) and the EtOAc 
extract showed the greatest antioxidant activity in the DPPH assay as well as the strongest 
inhibition of xanthine oxidase (XO) and 15-lipoxygenase (15-LO). From these results, the 
extract of B. umbraculum might be a valuable source of flavone C-glycosides. 
Keywords: Biophytum umbraculum; flavone-C-glycosides; DPPH; xanthine oxidase;  
15-lipoxygenase 
 
1. Introduction 
Biophytum umbraculum Welw. (common syn. Biophytum petersianum Klotzsch) (Oxalidaceae) is a 
slender annual herb distributed in tropical and subtropical Africa, and across to Asia and New Guinea. 
The aerial parts of the plant have several medicinal uses in Mali and other African countries [1]. 
OPEN ACCESS
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Ethnopharmacological surveys on the use of B. umbraculum by practitioners in different districts in 
Mali (Bamako, Siby and Dioila) show that the plant is frequently used against cerebral malaria, but 
also against hemorrhoids, colonic ailments, wounds, stomach ache and fever [2–4]. In Nigeria the plant 
has been used against wounds, gonorrhea, urethral stones and stomach ache [1]. Other indications 
reported are constipation, hypertension, migraine, epilepsy, breathing difficulties and lack of  
fertility [1,5,6]. Various in vitro studies indicate that extracts of B. umbraculum may exert beneficial 
pharmaceutical effects on hypertension [5,7–10]. In addition, pectic polysaccharides isolated from B. 
umbraculum have demonstrated diverse effects on the immune system by virtue of complement 
fixation [3,4], activation of macrophages and dendritic cells [11], and modulation of intestinal Peyer’s 
patch cells [12]. Phytochemical investigations on B. umbraculum have so far been restricted to 
polysaccharides [3,4,11,12], although saponins of unknown structure have been stated to be present in 
aqueous extracts of the plant [13]. 
In the past decades, there has been a growing interest in antioxidants and free radical scavengers as 
they may have an important role in the prevention of pathologies in which reactive oxygen species 
(ROS) or free radicals are implicated, such as atherosclerosis, cardiovascular diseases (CVD), 
ischemia/reperfusion injury, neurodegenerative diseases and cancer [14,15]. As a part of an ongoing 
project on Malian medicinal plants [16–18], in the present study chemical characterization and 
investigation of antioxidant activity were performed on B. umbraculum. 
2. Results and Discussion 
2.1. Isolation and Structural Elucidation 
Compounds 1, 2 and 3 were isolated from the EtOAc soluble fraction of the MeOH crude extract of 
Biophytum umbraculum by column chromatography (CC).  Based on the weights of purified fractions, 
estimated concentrations of substances in the crude MeOH extract are 0.45% (1), 0.37% (2) and 0.17% (3). 
The compounds were identified as cassiaoccidentalin A (1), isovitexin (2) and isoorientin (3), 
respectively, by comparing their 1H-NMR and 13C-NMR spectroscopic data with those reported in the 
literature [19–21]. Besides, the COSY spectrum revealed 1H-1H couplings and helped assign proton 
resonances, especially those of the inner sugar of 1. The HSQC spectrum showed all 1J direct 1H-13C 
correlations and thus confirmed the assignments of all signals arising from the CH- and CH2- groups. 
Among all the 1H-13C long-range correlations observed in the HMBC spectrum, the most important 
were the correlations from the anomeric proton of the inner sugar (H-1ƍ) to C-6 (2J), C-5 (3J) and C-7 (3J) 
of the aglycone, which confirmed the C-glycosylation at C-6. 
The chemical structures of the three flavone-C-glycosides are shown in Figure 1. To our 
knowledge, this is the first identification of flavone-C-glycosides in B. umbraculum. Compound 1 is a 
very rare flavone-C-glycoside which has only been identified once before, in Cassia occidentalis [19], 
whereas the more common flavone glucosides 2 and 3 have been identified in another Biophytum 
species, namely Biophytum sensitivum [22]. 
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Figure 1. Chemical structures of the three flavone-C-glycosides 1–3. 
 
2.2. Antioxidant Activity 
The dichloromethane (DCM) crude extract of B. umbraculum was virtually inactive as a DPPH 
radical scavenger, xanthine oxidase (XO) and 15-lipoxygenase (15-LO) inhibitor (IC50 > 167 μg/mL). 
The MeOH crude extract and the semi-polar extracts obtained by partitioning the MeOH extract 
showed fairly high radical scavenger activity and 15-LO inhibition (Table 1). The extracts showed 
moderate or low inhibitory activity towards XO compared to the positive control quercetin. The EtOAc 
extract exhibited the highest activity in all three assays. 
Table 1. DPPH radical scavenging, xanthine oxidase (XO) inhibition and 15-lipoxygenase 
(15-LO) inhibition of Biophytum umbraculum extracts. IC50 values ± SD (in μg/mL)  
are shown. 
Extract DPPH XO 15-LO 
DCM crude extract >167 >167 >167 
MeOH crude extract 13.4 ± 0.6 59.7 ± 6.1 68.9 ± 5.0 
EtOAc extract 6.8 ± 0.6 ca. 21 43.0 ± 3.6 
BuOH extract 12.5 ± 1.9 102.6 ± 5.6 53.4 ± 2.1 
Aqueous residue 29.8 ± 3.5 >167 >167 
Quercetin (positive control) 4.4 ± 0.4 2.33 ± 0.09 33.4 ± 0.3 
The activity of the isolated compounds as DPPH scavengers, XO- and 15-LO inhibitors is shown in 
Table 2. Flavone-C-glycosides were found to contribute both as DPPH scavengers and 15-LO 
inhibitors in the EtOAc extract. This is in good accordance with previous structure-activity studies 
indicating the importance of a 2,3 double bond in conjugation with a 4-oxo function in the C-ring and  
o-dihydroxy structure in the B-ring [23,24]. The strongest inhibitor of XO and 15-LO and the best 
DPPH scavenger was isoorientin. The strong DPPH radical scavenging activity of isoorientin and the 
much weaker activity of isovitexin are supported by previous results [25,26]. This antioxidant activity 
clearly shows that the 3ƍ,4ƍ-dihydroxy structural element of isoorientin is of importance for activity, 
isoorientin having an IC50 value similar to the positive control quercetin. This is in accordance with a 
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previous report [27]. The EtOAc extract may contain additional unidentified XO inhibitors, since XO 
inhibition of the isolated compounds does not account for the activity observed in the EtOAc extract. It 
has previously been suggested that flavones without a glycosyl group were relatively strong inhibitors 
of XO, as the presence of a glycosyl group would decrease the inhibitory activity [28,29]. XO and  
15-LO inhibitors may be beneficial for diseases and conditions such as ischemia/reperfusion, gout, 
renal stones, inflammation, arteriosclerosis, neurodegenerative diseases, cancer, aging, etc. [28,30–32]. 
Additionally, XO-inhibitors may have beneficial effects as adjuncts in the management of severe 
Plasmodium falciparum malaria [33]. 
Since the solubility in water of the flavonoids reported here is unknown (although a calculation, as 
given on the SciFinder website, gives theoretical values of between 0.12 and 0.15 mg/mL), an analysis 
of aqueous extracts of the plant may be relevant for the evaluation of its ethnopharmacological use, 
and might thus represent a useful continuation of the present work. 
These results imply that the extracts from B. umbraculum are a rich source of flavone-C-glycosides, 
and that herbal remedies obtained from this plant may have an effect against inflammations or other 
diseases related to oxidative stress. The results from our study would seem to be in accord with several 
of the reported ethnopharmacological usages of the plant. 
Table 2. Effects of isolated compounds from B. umbraculum on DPPH radical scavenging, 
xanthine oxidase (XO) inhibition and 15-lipoxygenase (15-LO) inhibition. IC50 values ± SD 
(in μM) are shown. 
Isolated compound DPPH XO 15-LO 
Cassiaoccidentalin A (1) >167 149.5 ± 7.4 99.9 ± 2.5 
Isovitexin (2) 96.0 ± 3.6 >167 107.1 ± 2.1 
Isoorientin (3) 18.1 ± 1.1 117.2 ± 13.5 86.4 ± 0.5 
Quercetin (positive control) 13.7 ± 1.3 7.7 ± 0.3 110.6 ± 1.0 
3. Experimental 
3.1. General 
1D and 2D NMR spectra were recorded on Bruker DPX 300 or Bruker AVII 400 instruments with 
CD3OD as solvent and TMS as internal standard. CC was done over Sephadex LH-20 (Pharmacia) or 
reverse phase (RP) silica (VersaPak C18 cartridges; Supelco). Fractions from CC were combined as 
indicated by TLC. Foils coated with Si gel RP-18 F254S (Merck) were used for analytical and 
preparative TLC. In analytical TLC, spots were visualized by UV irradiation (254 and 366 nm) and by 
spraying with Ce(SO4)2 (1% in 10% aqueous H2SO4) followed by heating (100 °C, 10–15 min). For 
UV/VIS measurements, a Biochrom Libra S32 PC instrument was employed. 
3.2. Plant Material 
Flowering, whole aerial parts of Biophytum umbraculum Welw. (Oxalidaceae) were collected in 
Blendio, Mali. The plant was identified by one of the authors, Prof. Drissa Diallo. A voucher specimen 
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(NO. 2653 DMT) was deposited in the herbarium at the Department of Traditional Medicine (DMT), 
Bamako, Mali. 
3.3. Extraction and Isolation 
The dried and powdered aerial parts of B. umbraculum (305 g) were extracted at RT with DCM  
(4 × 2.5 L), each time for 24 h, yielding 5.1 g of DCM extract (1.7% yield). The plant residue was then 
extracted similarly with MeOH (5 × 2.5 L) to yield 17.7 g (5.8%) of MeOH extract. The MeOH extract 
was suspended in 3 × 100 mL distilled water and successively partitioned with EtOAc (6 × 300 mL) 
and BuOH (5 × 200 mL). The solvents were removed under vacuum, affording an EtOAc extract  
(4.6 g), a BuOH extract (5.3 g) and an aqueous residue (5.0 g). The EtOAc (E) extract was 
chromatographed over Sephadex LH-20 (2.5 × 74 cm) with a gradient of H2O/MeOH (25%–100% 
MeOH) to yield 15 subfractions (E1-E15). E9 (334 mg), E10 (1,029 mg) and E11 (555 mg) were 
chosen for isolation of bioactive compounds based on fraction weights, pattern in NMR spectra and 
results from activity assays. E9 was flash chromatographed over RP C-18 Si gel (VersaPak, 2.3 × 11 cm) 
eluting with a H2O-MeOH gradient (40%–100% MeOH) to give 1 (57 mg). E10 was applied to a  
RP C-18 Si gel VersaPak column (4 × 15 cm) and eluted with a gradient of H2O-MeOH  
(20%–100% MeOH) to afford E10.1-E10.9. E10.6 (42 mg) and E10.7 (24 mg) were combined and 
rechromatographed over a smaller VersaPak column (2.3 × 11 cm) with a H2O-MeOH gradient  
(20%–100% MeOH) followed by preparative TLC to give 2 (8.8 mg). E11 was flash chromatographed 
with the same column as used for E10 and eluted with a gradient of H2O-MeOH (40%–100% MeOH) 
to yield E11.1-E11.13. E11.2 (50 mg) and E11.3 (21 mg) were combined and purified using the same 
system to give 3 (6.5 mg). A second batch of plant material (225 g) was subjected to Soxhlet extraction 
(2 L DCM for 48 h, followed by 3 L MeOH for 48 h). Yield of DCM extract was 7.5 g (3.3%), and of 
MeOH extract 17.2 g (7.6%). EtOAc extract (4.6 g), BuOH extract (3.3 g) and aqueous residue (5.1 g) 
were obtained similarly as above. 
3.4. DPPH Radical Scavenging 
Pure substances and crude extracts (Soxhlet) were dissolved in DMSO, and the assay was carried 
out as reported previously [34]. Quercetin (Sigma-Aldrich) was used as positive control. 
3.5. Inhibition of Xanthine Oxidase (XO) 
Pure substances and crude extracts (Soxhlet) were dissolved in DMSO, and the assay was carried 
out as reported previously [35]. Quercetin (Sigma-Aldrich) was used as positive control. 
3.6. Inhibition of 15-Lipoxygenase (15-LO) 
Pure substances and crude extracts (Soxhlet) were dissolved in DMSO, and the assay was carried 
out as reported previously [34]. Quercetin (Sigma-Aldrich) was used as positive control. 
3.7. Statistical Analysis 
All samples were analyzed in triplicates and the results are shown as mean ± standard deviation (SD). 
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4. Conclusions 
Our phytochemical study led to the isolation and characterization of three flavone-C-glycosides 
from the aerial parts of B. umbraculum. This is the first report on this type of compound from this 
plant. Compound 3 and the EtOAc extract of the plant revealed strong antioxidant activity towards 
DPPH radical and 15-LO, and moderate activity towards XO. Further studies on these extracts with 
respect to antioxidant properties in vivo are needed. 
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